$141 Thousand is the total value of Rye Brook Capital LLC's 28 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LQD | Sell | ISHARES IBOXX INVESTMENT GRAetf | $37,834 | -7.1% | 370,850 | -1.5% | 26.92% | +40.0% |
| EWJ | Sell | ISHARES MSCI JAPAN ETFetf | $19,251 | -3.4% | 319,300 | -0.8% | 13.70% | +45.5% |
| VGK | Sell | VANGUARD FTSE EUROPE ETFetf | $15,618 | -6.8% | 269,600 | -0.8% | 11.11% | +40.4% |
| VMI | Sell | VALMONT INDUSTRIES | $432 | -62.9% | 1,800 | -55.0% | 0.31% | -44.2% |
| QQQ | Exit | INVESCO QQQ TRUST SERIES 1etf | $0 | – | -109,400 | -100.0% | -19.09% | – |
| QQQ | Exit | INVESCO QQQ TRUST SERIES 1put | $0 | – | -1,194 | -100.0% | -20.83% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES MSCI JAPAN ETF | 12 | Q3 2023 | 14.8% |
| ISHARES NASDAQ BIOTECHNOLOGY | 12 | Q3 2023 | 7.7% |
| VANGUARD REAL ESTATE ETF | 12 | Q3 2023 | 6.0% |
| EQUITY RESIDENTIAL | 12 | Q3 2023 | 2.3% |
| AVALONBAY COMMUNITIES INC | 12 | Q3 2023 | 2.2% |
| INVESCO QQQ TRUST SERIES 1 | 11 | Q2 2023 | 29.1% |
| VANGUARD FTSE EUROPE ETF | 9 | Q3 2023 | 18.9% |
| VANECK SEMICONDUCTOR ETF | 9 | Q1 2023 | 8.8% |
| BLOOMIN' BRANDS INC | 9 | Q3 2023 | 4.1% |
| TRITON INTERNATIONAL LTD | 9 | Q1 2023 | 3.1% |
View Rye Brook Capital LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-11 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-10-10 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-04-21 |
| 13F-HR | 2023-01-06 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-07-21 |
| 13F-HR | 2022-04-28 |
| 13F-HR | 2022-01-12 |
View Rye Brook Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.